Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type Sort ascending
    Focus Area
    Country
    Application Due Date
    Closing the Gaps within Intestinal Ultrasound
    Release Date:
    Partner: International Bowel Ultrasound Group
    Review Process: Expert Review Panel
    Research Inflammation & Immunology All
    BOOST - Multiple Myeloma An Oncology Boosting Program
    Release Date:
    Review Process: Expert Review Panel
    Translation:(link)
    Quality Improvement Oncology Netherlands
    2025 Rheumatology Fellowship – United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Inflammation & Immunology USA
    Addressing Healthcare Disparities in the Outpatient Diagnosis and Management of COVID-19
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    USP <797> Pharmaceutical Compounding-Sterile Preparations: Ensuring Compliance Now and For the Future
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital USA
    Education for Patients and Caregivers Living with Bladder Cancer from NMIBC to la/mUC
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Education in the Era of Emerging Hemophilia Therapy
    Release Date:
    Partner: National Bleeding Disorders Foundation
    Review Process: Expert Review Panel
    Education Rare Disease Guam, Puerto Rico, USA
    PARP-Inhibitor Combination Treatments: Safety and Efficacy in a rapidly changing mCRPC landscape
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology All
    Clinical Data Updates & Treatment Management Strategies in First-line ALK-positive Metastatic Non-Small Cell Lung Cancer(NSCLC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Increase Awareness & Understanding of Emerging Hemophilia Treatment Options
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Optimizing Testing and Treatment in Metastatic Colorectal Cancer (mCRC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
  • Title
    Grant Type Sort ascending
    Focus Area
    Country
    Application Due Date
    Global Awards for Research in DMD-AWARD
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    Patient Preferences for Drug Delivery: Literature Review
    Release Date:
    Review Process: Expert Review Panel
    Research Support for the Professions All
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in Latin America
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Accelerating Advancements in Women’s Health
    Release Date:
    Partner: Myovant Sciences
    Review Process: Expert Review Panel
    Research Internal Medicine USA
    Project to Evaluate the Effectiveness of Elranatamab in the Treatment of Multiple Myeloma
    Release Date:
    Partner: National Comprehensive Cancer Network
    Review Process: Expert Review Panel
    Research Oncology USA
    Combination Therapy with Relugolix in the Treatment of Advanced Prostate Cancer
    Release Date:
    Partner: National Comprehensive Cancer Network; Myovant Sciences
    Review Process: Expert Review Panel
    Research Oncology USA
    Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease USA
    Junior Investigator Global ATTR Amyloidosis Research ASPIRE (All countries except for the United States)
    Release Date:
    Review Process: Expert Review Panel
    Research Rare Disease All
    2023 Global Migraine ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    2022/2023 Global COVID-19 ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Hospital All
    2022/2023 Global Cachexia ASPIRE
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine All
    2023 Growth Hormone Research
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All